$222.19
-0.72-0.32%
Pre-Market: 7:22 PM EDT
Comments
Loading...
ResMed Earnings Estimates, EPS & Revenue | NYSE:RMD | Benzinga
ResMed reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 24
EPS Estimate
$2.390
Quarterly Revenue Estimate
$1.30B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$4.93B
Analyze the earnings history of ResMed using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | ResMed | $2.13 | $2.39 | — | — | $1.20B | $1.30B | — | — | 04/24/2025 | Get Alert |
| RMD | ResMed | $1.88 | $2.31 | $2.43 | 5.19% | $1.16B | $1.27B | $1.28B | 0.94% | 01/30/2025 | Get Alert |
| RMD | ResMed | $1.64 | $2.04 | $2.20 | 7.84% | $1.10B | $1.18B | $1.23B | 3.81% | 10/24/2024 | Get Alert |
| RMD | ResMed | $1.60 | $2.06 | $2.08 | 0.97% | $1.12B | $1.19B | $1.22B | 2.77% | 08/01/2024 | Get Alert |
| RMD | ResMed | $1.68 | $1.91 | $2.13 | 11.52% | $1.12B | $1.17B | $1.20B | 2.31% | 04/25/2024 | Get Alert |
| RMD | ResMed | $1.66 | $1.79 | $1.88 | 5.03% | $1.03B | $1.15B | $1.16B | 1.13% | 01/24/2024 | Get Alert |
| RMD | ResMed | $1.51 | $1.62 | $1.64 | 1.23% | $950.29M | $1.10B | $1.10B | 0.18% | 10/26/2023 | Get Alert |
| RMD | ResMed | $1.49 | $1.67 | $1.60 | -4.19% | $914.74M | $1.12B | $1.12B | 0.18% | 08/03/2023 | Get Alert |
| RMD | ResMed | $1.32 | $1.59 | $1.68 | 5.66% | $864.50M | $1.05B | $1.12B | 6.37% | 04/27/2023 | Get Alert |
| RMD | ResMed | $1.47 | $1.60 | $1.66 | 3.75% | $894.87M | $994.02M | $1.03B | 4.02% | 01/26/2023 | Get Alert |
| RMD | ResMed | $1.51 | $1.52 | $1.51 | -0.66% | $904.01M | $941.17M | $950.29M | 0.97% | 10/27/2022 | Get Alert |
| RMD | ResMed | $1.35 | $1.51 | $1.49 | -1.32% | $876.10M | $912.97M | $914.74M | 0.19% | 08/11/2022 | Get Alert |
| RMD | ResMed | $1.30 | $1.42 | $1.32 | -7.04% | $768.77M | $897.04M | $864.50M | -3.63% | 04/28/2022 | Get Alert |
| RMD | ResMed | $1.41 | $1.52 | $1.47 | -3.29% | $800.01M | $935.25M | $894.87M | -4.32% | 01/27/2022 | Get Alert |
| RMD | ResMed | $1.27 | $1.36 | $1.51 | 11.03% | $751.94M | $866.33M | $904.01M | 4.35% | 10/28/2021 | Get Alert |
| RMD | ResMed | $1.33 | $1.28 | $1.35 | 5.47% | $770.34M | $783.18M | $876.10M | 11.86% | 08/05/2021 | Get Alert |
| RMD | ResMed | $1.29 | $1.28 | $1.30 | 1.56% | $769.46M | $801.83M | $768.77M | -4.12% | 04/29/2021 | Get Alert |
| RMD | ResMed | $1.21 | $1.26 | $1.41 | 11.90% | $736.16M | $783.18M | $800.01M | 2.15% | 01/28/2021 | Get Alert |
| RMD | ResMed | $0.93 | $0.99 | $1.27 | 28.28% | $681.06M | $699.03M | $751.94M | 7.57% | 10/29/2020 | Get Alert |
| RMD | ResMed | $0.95 | $1.08 | $1.33 | 23.15% | $704.96M | $746.90M | $770.34M | 3.14% | 08/05/2020 | Get Alert |
| RMD | ResMed | $0.89 | $1.03 | $1.29 | 25.24% | $662.23M | $719.57M | $769.46M | 6.93% | 04/30/2020 | Get Alert |
ResMed (RMD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-01-30 | $2.43 | $2.31 | 5.19 % |
| Q1 | 2024-10-24 | $2.20 | $2.04 | 7.84 % |
| Q4 | 2024-08-01 | $2.08 | $2.06 | 0.97 % |
| Q3 | 2024-04-25 | $2.13 | $1.91 | 11.5 % |
ResMed (RMD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-01-30 | $1.28B | $1.27B | 0.94 % |
| Q1 | 2024-10-24 | $1.23B | $1.18B | 3.81 % |
| Q4 | 2024-08-01 | $1.22B | $1.19B | 2.77 % |
| Q3 | 2024-04-25 | $1.20B | $1.17B | 2.31 % |
FAQ
When is ResMed (NYSE:RMD) reporting earnings?
ResMed (RMD) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on January 30, 2025 for Q2.
What were the latest earnings per share (EPS) for ResMed (NYSE:RMD)?
The Actual EPS was $2.43, which beat the estimate of $2.31.
What were ResMed’s (NYSE:RMD) revenues?
The Actual Revenue was $1.3B, which beat the estimate of $1.3B.
Browse earnings estimates, EPS, and revenue on all stocks.